Mark Eaton is president and CEO of Stellarray Inc., a company he founded in 2008 as a spin-off of Stellar Micro Devices (SMD). Stellarray develops and manufactures flat panel radiation sources and systems, using them to solve important problems in irradiation and imaging. The first branded product is a self-contained blood irradiator (SCBI) which uses the company’s proprietary flat panel x-ray sources (FPXS) to ensure the safety of transfusion blood supplies. Stellarray’s digitally addressable “smart” x-ray sources enable CT systems with no moving parts for improved medical and industrial imaging at drastically lower radiation doses. Systems currently under development include a more accurate digital mammography system, a field portable CT system for military and emerging market use, and parallel imaging sources for phase contrast imaging and dose reduction.
Mr. Eaton previously built SMD into a successful R&D firm in the area of vacuum microelectronics, with accomplishments in microwave devices, 3D displays and vacuum transistors. Before founding SMD he was vice president for strategy and development at the Microelectronics and Computer Technology Corporation (MCC), a consortium of US technology companies, following which he assisted several MCC members and spin-offs in business development, technology licensing, and strategic alliances.
Mr. Eaton was previously vice consul for economic and technology affairs at the US Consulate in Osaka-Kobe, Japan. He has served as an advisor to the US Defense Manufacturing Board and Congressional Office of Technology Assessment.
Mr. Eaton was educated at the Johns Hopkins University (BA, with general and departmental honors, 1977), the Johns Hopkins School of Advanced International Studies (MA, with distinction, 1980) and Harvard Business School (program for Management Development, 1990). He has written on Japanese industrial policy, technology forecasting, and the use of strategic alliances in technology development. Mr. Eaton is named as inventor for five issued US patents and several patents pending.
